Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of GMFFP From Young Healthy Donors (18-35), Treated With G-CSF to Ameliorate Frailty and Enhance the Immune Risk Profile in Older Individuals

NCT03458429 is registered in ClinicalTrials.gov with Dipnarine Maharaj as lead sponsor.

NCT NCT03458429
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03458429 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of GMFFP From Young Healthy Donors (18-35), Treated With G-CSF to Ameliorate Frailty and Enhance the Immune Risk Profile in Older Individuals
Lead sponsor
Dipnarine Maharaj
Phase
Phase 1/2
Overall status
Enrolling by invitation
Start date
February 5, 2018
Completion date
December 30, 2030
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

frailty